Acute hemodynamic and renal effects of the endothelin-1 receptor antagonist TAK-044 in patients without heart failure

被引：0
|
作者：
Sutsch, G
Fleisch, M
Yan, XW
Wenzel, R
Binggeli, C
Bianchetti, MC
Kiowski, W
Luscher, T
机构：
[1] UNIV HOSP BERN,CARDIOL UNIT,CH-3010 BERN,SWITZERLAND
[2] UNIV ZURICH HOSP,CH-8091 ZURICH,SWITZERLAND
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 1997年 / 29卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：52132 / 52132
页数：1
相关论文
共 50 条
  • [31] Effects of long-term treatment with nonselective endothelin receptor antagonist, TAK-044, on remodeling of cardiovascular system with sustained volume overload
    Tojo, T
    Tsunoda, Y
    Nakada, S
    Tomoike, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (05) : 777 - 785
  • [32] Effects of an endothelin receptor antagonist, TAK-044, on ischemia-reperfusion injury after 18-hour preserved lung transplantation
    Mizutani, H
    JAPANESE JOURNAL OF TRANSPLANTATION, 1998, 33 (01) : 10 - 18
  • [33] Acute effects of an endothelin-1 receptor antagonist bosentan at different stages of heart failure in conscious dogs
    Choussat, R
    Hittinger, L
    Barbe, F
    Maistre, G
    Carayon, A
    Crozatier, B
    Su, JB
    CARDIOVASCULAR RESEARCH, 1998, 39 (03) : 580 - 588
  • [34] Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the cirrhotic rat liver
    Kitayama, Y
    Yamanaka, N
    Okamoto, E
    Kusumoto, K
    Fujiwara, A
    Watanabe, T
    HEPATOLOGY RESEARCH, 1998, 13 (01) : 1 - 9
  • [35] Pretreatment of donors with endothelin receptor antagonist TAK-044 improves cardiac functional recovery following preservation with University of Wisconsin solution
    Kaneda, T
    Zhang, ZW
    Ogawa, T
    Otaki, M
    Saga, T
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2002, 36 (02) : 105 - 107
  • [36] Effects of TAK-044, a nonselective endothelin receptor antagonist, on the spontaneous and indomethacin- or methylene blue-induced constriction of the ductus arteriosus in rats
    Takizawa, T
    Horikoshi, E
    Shen, MH
    Masaoka, T
    Takagi, H
    Yamamoto, M
    Kasai, K
    Arishima, K
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2000, 62 (05): : 505 - 509
  • [37] Reduction of progressive burn injury by using new nonselective endothelin-A and endothelin-B receptor antagonist, TAK-044: An experimental study in rats
    Battal, MN
    Hata, Y
    Matsuka, K
    Ito, O
    Matsuda, H
    Yoshida, Y
    Kawazoe, T
    PLASTIC AND RECONSTRUCTIVE SURGERY, 1997, 99 (06) : 1610 - 1619
  • [38] Results of a randomized, placebo-controlled, hemodynamic trial with an intravenous endothelin-1 receptor antagonist in patients with congestive heart failure
    Torre-Amione, G
    Durand, JB
    Bozkurt, B
    Vooletich, MT
    Young, JB
    Pratt, CM
    Charlon, V
    Widman, T
    CIRCULATION, 1999, 100 (18) : 647 - 647
  • [39] Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure
    Torre-Amione, G
    Young, JB
    Colucci, WS
    Lewis, BS
    Pratt, C
    Cotter, G
    Stangl, K
    Elkayam, U
    Teerlink, JR
    Frey, A
    Rainisio, M
    Kobrin, I
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) : 140 - 147
  • [40] Adverse hemodynamic effects of a selective endothelin ETB receptor antagonist in patients with chronic heart failure:: reversal with a selective endothelin ETA receptor antagonist
    Cowburn, PJ
    Cleland, JGF
    McDonagh, TA
    McArthur, JD
    MacLean, MR
    Dargie, HJ
    CIRCULATION, 1998, 98 (17) : 718 - 718
12345